+44 (0) 207 788 7828

info@biotherapyservices.com

 

Company

4. GMP process of RAPID Haematogel

Company Overview

 

Biotherapy Services Ltd. is a clinical stage, pharmaceutical biotechnology company developing and delivering novel autologous therapies for complex and chronic wounds.

The company has developed proprietary expertise and a unique GMP standard operational service model to provide the proprietary RAPID™ Biodynamic Haematogel autologous wound care treatment, targeting complex and chronic wounds such as diabetic foot ulcers and pressure sores.

The future landscape of cellular therapies.

 

Biotherapy Service Ltd. is specifically is specifically focused on complex wound care surgery.

The clinical adoption of these cellular therapies and their effective utilisation were based on 4 specific factors:

 

  • Meeting the rapidly changing regulatory environment.
  • UK based clinical studies to substantiate their safety and efficacy.
  • A GMP production that provides the necessary expertise for a complex service to be delivered at point-of-care.
  • Providing peer to peer  specialist clinician support  to introduce these biological therapies into clinical practice.
5. Apply RAPID Haematogel to wound
5. Apply RAPID Haematogel to wound

The future landscape of cellular therapies.

 

Biotherapy Service Ltd. is specifically is specifically focused on complex wound care surgery.

The clinical adoption of these cellular therapies and their effective utilisation were based on 4 specific factors:

 

  • Meeting the rapidly changing regulatory environment.
  • UK based clinical studies to substantiate their safety and efficacy.
  • A GMP production that provides the necessary expertise for a complex service to be delivered at point-of-care.
  • Providing peer to peer  specialist clinician support  to introduce these biological therapies into clinical practice.